Market View 12th August 2022

View on market: Stay Cautious, be with quality business:

US futures fluctuated after the S&P 500 and Nasdaq 100 gave up intraday gains to end in the red. Stocks in Asia got a lift from Japan on Friday while Treasuries were mixed as investors evaluated how far the Federal Reserve must jack up interest rates to ensure high inflation keeps cooling. Elsewhere, oil gained as fears of a slowdown in demand eased after IEA lifted consumption estimates. Gold fluctuated and Bitcoin went above $24,000. Back home, India’s stock benchmarks closed higher after softer-than-expected U.S. inflation print raised expectations that the Federal Reserve will hike interest rates at a slower pace. The local currency depreciated against the U.S. dollar on Thursday amid rising crude oil prices.

Economic Calendar:

• USD : Import Price Index (MoM) (Jul) 12^th Aug, 2022
• USD : Import Price Index (MoM) (Jul) 12^th Aug, 2022
• INR : Trade Balance 12^th Aug, 2022
• INR : CPI (YoY) (Jul) 12^th Aug, 2022

Q1FY23 Result Today: ONGC, LIC, Hero MotoCorp, Grasim Industries, Divis Labs, Zee Entertainment, Aegis Logistics, Ahluwalia Contracts, Apollo Tyres, Astral, Bajaj Electricals, Bajaj Healthcare, Bajaj Hindusthan Sugar, Balaji Amines, Bharat Dynamics, Campus Activewear, Dilip Buildcon, Dhani Services, Finolex Cables, Godrej Industries, Hindustan Aeronautics, Indiabulls Real Estate, India Cements, Info Edge

Q1FY23 Result:

Aurobindo Pharma Q1 FY23 (Consolidated, YoY) reported a 32.4% YoY growth in consolidated profit at Rs 520.4 crore for the quarter ended June FY23, impacted by lower other income and operating income. Revenue grew by 9.4% to Rs 6,236 crore compared to year-ago period, with US formulations business increasing 10.8%, but Europe formulation business fell 2.2% mainly due to euro currency depreciation.

KNR Constructions Q1 FY23 (Consolidated, YoY) registered a 20.3% YoY decline in consolidated profit at Rs 89.61 crore for the quarter ended June FY23, impacted by tepid growth in operating income and higher raw material cost. Revenue grew by 21.5% to Rs 980.45 crore and EBITDA increased by 4.2% to Rs 211.25 crore compared to year-ago period.

Apollo Hospitals Q1 FY23 (Consolidated YoY) reported a 35.3% YoY decline in consolidated profit at Rs 323.8 crore for the June FY23 quarter on a high base. Revenue increased by 0.94% to Rs 3,795.60 crore compared to corresponding period last fiscal.

Brokerage Radar:

UBS ON BHARAT FORGE: Maintain BUY, TP Rs 900; Q1FY23 Standalone EBITDA beat consensus by 8-9%; Outlook remains relatively strong; Global CV expected to fell atleast until the end of CY23; Margin performance one of the best among the auto components; Will beneft from fomestic CV demand recovery & strong export outlook

CS ON CUMMINS: Maintain OP, TP Rs 1475; Continue to look attractive even for modest cyclical pay; Supply chain issue still persist; Revise Earnings by +1%/9% for FY23/24; Stock continue to look attractive at 30x FY24E

JEFFERIES ON TRENT: Maintains Hold, TP 1300, Witnessed sharp growth in Revenue in Q1, much ahead of estimates; 3 year revenue CAGR at 30% is impressive; Gross Margin declines as intensity in discounting and promotions returned; Revise estimates by 7-9%

International Markets:

U.S & Europe:

Asian markets:

ADR Watch:

Commodities & Currency:

FIIs & DIIs:

News Update:

Sterling and Wilson Renewable Energy: Promoter Shapoorji Pallonji will offload 1.25% stake in the company via offer for sale. The floor price is Rs 270 apiece.

Voltas: Life Insurance Corporation raised its stake in the company to 6.86% from 4.83%.

Balaji Amines: Subsidiary, Balaji Speciality Chemicals, has filed a draft red herring prospectus with the Sebi for fund raising via initial public offering. The offer consists of a fresh issue of equity shares worth Rs 250 crore and an offer for sale of 2.6 crore shares by certain existing and eligible shareholders

Source: Moneyontrol, Livemint,, Bloomberg, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL